Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-04T20:18:46.628Z Has data issue: false hasContentIssue false

14 - Diagnosis and treatment of osteoporosis

from Part III - Disease prevention

Published online by Cambridge University Press:  21 August 2009

Jeannette E South-Paul
Affiliation:
Department of Family Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Jo Ann Rosenfeld
Affiliation:
The Johns Hopkins University
Get access

Summary

Introduction

Osteoporosis is a major public health problem, affecting more than 40 million people, one-third of postmenopausal women, and a substantial portion of the elderly in the USA, Europe, and Japan. An additional 54% of postmenopausal women have low bone density measured at the hip, spine, or wrist. Osteoporosis results in more than 1500000 fractures annually in the USA.

The direct expenditures for osteoporotic fractures have increased during the past decade from $5 billion to approximately $15 billion annually. Of the 25 million women in the USA who have osteoporosis, eight million have a documented fracture. The female-to-male fracture ratios are 7:1 for vertebral fractures, 1.5:1 for distal forearm fractures, and 2:1 for hip fractures. Approximately 70% of hip fractures in individuals older than 65 years of age occur in women. Osteoporosis-related fracture in older men is associated with lower femoral neck bone mineral density (BMD), quadriceps weakness, higher body sway, lower body weight, and decreased stature.

Osteoporotic fractures are more common in white people and Asian people than in African-Americans and Hispanics, and more common in women than in men. Little is known regarding the influence of ethnicity on bone turnover. Factors such as differences in bone accretion are likely to be responsible for much of the ethnic variation in adult BMD.

Prevention

Nutritional prevention

Bone mineralization depends on adequate nutritional status in childhood and adolescence. Therefore, measures to prevent osteoporosis should begin with improving the nutritional status of adolescents to increase bone mineralization, including increasing milk intake.

Type
Chapter
Information
Women's Health in Mid-Life
A Primary Care Guide
, pp. 235 - 252
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Melton, L. J.How many women have osteoporosis?J. Bone Miner. Res. 1992; 7:1005–10CrossRefGoogle ScholarPubMed
Cooper, C. and Melton, L. J., III. Epidemiology of osteoporosis. Trends Endocrinol. Metab. 1992; 314:224–9CrossRefGoogle Scholar
www.nof.org/osteoporosis/stats.htm. Accessed March 2003
Taxel, P.Osteoporosis: detection, prevention, and treatment in primary care. Geriatrics 1998; 53:22–33Google ScholarPubMed
Finkelstein, J. S., Sowers, M., Greendale, D. A., et al.Ethnic variation in bone turnover in pre- and early perimenopausal women: effects of anthropometric and lifestyle factors. J. Clin. Endocrinol. Metab. 2002;. 87:3051–6CrossRefGoogle ScholarPubMed
Cadogen, J.Eastell, R., Jones, N. and Barker, M. E.Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. Br. Med. J. 1997; 315:1255–60CrossRefGoogle Scholar
Eisman, J.Relevance of pregnancy and lactation to osteoporosis. Lancet 1998; 352:504–5CrossRefGoogle ScholarPubMed
Hotta, M., Shibasaki, T., Sato, K. and Demura, H.The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual x-ray absorptiometry and bone metabolic markers. Eur. J. Endocrinol. 1998; 139:276–83CrossRefGoogle ScholarPubMed
Ernst, E.Exercise for female osteoporosis. A systematic review of randomised clinical trials. Sports Med. 1998; 25:359–68CrossRefGoogle ScholarPubMed
Dalsky, G. P., Stocke, K. S., Ehsani, A. A., et al.Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann. Intern. Med. 1988; 108:824–8CrossRefGoogle ScholarPubMed
Chow, R., Harrison, J. E. and Notarius, C.Effect of two randomized exercise programs on bone mass of healthy postmenopausal women. Br. Med. J. 1987; 295:1441–4CrossRefGoogle Scholar
Kohrt, W. M., Snead, D. B., Slatopolsky, E. and Birge, S. J.Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J. Bone Miner. Res. 1995; 10:1303–11CrossRefGoogle Scholar
Nelson, M. E., Fiatarone, M. A., Morganti, C. M., et al.Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. J. Am. Med. Assoc. 1994; 272:1909–14CrossRefGoogle ScholarPubMed
Henderson, N. K., White, C. P. and Eisman, J. A.The role of exercise and fall risk reduction in the prevention of osteoporosis. Endocrinol. Metab. Clin. North Am. 1998; 27:369–87CrossRefGoogle Scholar
Drinkwater, B. L.Physical exercise and bone health. J. Am. Med. Womens Assoc. 1990; 45:91–97Google ScholarPubMed
Kroger, H. and Reeve, J.Diagnosis of osteoporosis in clinical practice. Ann. Med. 1998; 30:278–87CrossRefGoogle ScholarPubMed
World Health Organization. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis: Report of a WHO Study Group. Geneva: WHO; 1994
Arnaud, C. D.Osteoporosis: using “bone markers” for diagnosis and monitoring. Geriatrics 1996: 51:24–30Google Scholar
Genant, H. K.Current state of bone densitometry for osteoporosis. Radiographics 1998; 18:913–18CrossRefGoogle ScholarPubMed
Blake, G. M. and Fogelman, I.Applications of bone densitometry for osteoporosis. Endocrinol. Metab. Clin. North Am. 1998; 27:267–88CrossRefGoogle ScholarPubMed
Scientific Advisory Board, Osteoporosis Society of Canada. Clinical practice guidelines for the diagnosis and management of osteoporosis. Can. Med. Assoc. J. 1996; 155:1113–33
US Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore, MD: Williams & Wilkins; 1996
Umland, E. M., Rinaldi, C., Parks, S. M. and Boyce, E. G.The impact of estrogen replacement therapy and raloxifene on osteoporosis, cardiovascular disease, and gynecologic cancers. Ann. Pharmacother. 1999; 33:1315–28CrossRefGoogle ScholarPubMed
Ravn, P., Bidstrup, M., Wasnich, R. D.et al.Alendronate and estrogen–progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study: a randomized trial. Ann. Intern. Med. 1999; 131:935–42CrossRefGoogle Scholar
Roussouw, J., Anderson, G. L., Prentice, R. L., et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J. Am. Med. Assoc. 2002; 288: 32–33Google Scholar
Colditz, G. A., Hankinson, S. E., Hunter, D. J., et al.The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 1995; 332:1589–93CrossRefGoogle ScholarPubMed
Reid, I. R.The role of calcium and vitamin D in the prevention of osteoporosis. Endocrinol. Metab. Clin. North Am. 1998; 27:389–98CrossRefGoogle Scholar
Aloia, J. F., Vaswani, A., Yeh, J. K., et al.Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann. Intern. Med. 1994; 114:97–103CrossRefGoogle Scholar
Reid, I. R.The role of calcium and vitamin D in the prevention of osteoporosis. Endocrinol. Metab. Clin. North. Am. 1998; 27:389–98CrossRefGoogle Scholar
Avioli, L. V.The role of calcitonin in the prevention of osteoporosis. Endocrinol. Metab. Clin. North. Am. 1998; 27:411–18CrossRefGoogle Scholar
Overgaard, K., Hansen, M. A., Jansen, S. B. and Christiansen, C.Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose response study. Br. Med. J. 1992; 305:556–61CrossRefGoogle Scholar
Chestnut, C. H., Silverman, S. L., Adriano, K., et al.Salmon-calcintonin nasal spray prevents vertebral fractures in established osteoporosis. Final world wide results of the “PROOF”. Calcif. Tissue Int. 1999; 64 (supp 1):1–26Google Scholar
Watts, N. B.Treatment of osteoporosis with bisphosphonates. Endocrinol. Metab. Clin. North. Am. 1998; 27:419–39CrossRefGoogle ScholarPubMed
Devogelaer, J. P. Arisk–benefit assessment of alendronate in the treatment of involutional osteoporosis. Drug Saf. 1998; 19:141–54CrossRefGoogle ScholarPubMed
Black, D. M., Cummings, S. R., Karpf, D. B., et al.Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348:1535–41CrossRefGoogle ScholarPubMed
Saag, K. G., Enkey, R., Schnitzer, T. J., et. alAlendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N. Engl. J. Med. 1998; 339: 292–9CrossRefGoogle ScholarPubMed
Reginster, J. Y., Minne, H. W., Sorensen, O. H., et al.Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos. Int. 2000; 11:83–91CrossRefGoogle ScholarPubMed
Harris, S. T., Watts, N. B., Genant, H. K., et al.Effects of residronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. J. Am. Med. Assoc. 1999; 282:1344–52CrossRefGoogle Scholar
McClung, M.Therapy for fracture prevention. J. Am. Med. Assoc. 1999; 282; 687–9CrossRefGoogle ScholarPubMed
Kreig, M. A., Seydoux, C., Sandini, L., et al.Intravenous pamidonate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos. Int. 2001; 12: 112–16CrossRefGoogle Scholar
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., et al.Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N. Engl. J. Med. 1997; 337:1641–7CrossRefGoogle Scholar
Draper, M. W., Flowers, D. E., Huster, W. J., et al.A controlled trial of raloxifene HCL: impact on bone turnover and serum lipid profile in healthy postmenopausal women. J. Bone. Miner. Res. 1996; 11:835–42CrossRefGoogle Scholar
Willhite, S. L., Goebel, S. R. and Scoggin, J. A.Raloxifene provides an alternative for osteoporosis prevention. Ann. Pharmacother. 1998; 32:834–7CrossRefGoogle ScholarPubMed
Ettinger, B., Black, D. M., Mitlak, B. H., et al.Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. results from a 3 year randomized clinical trial.”J. Am. Med. Assoc. 1999; 282:637–45CrossRefGoogle Scholar
Fugh-Berman, A.Progesterone cream for osteoporosis. Altern. Ther. Womens Health 1999; 1:33–40Google Scholar
Potter, S. M., Baum, J. A., Teng, H., et al.Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 1998; 68(supp):1375–9CrossRefGoogle ScholarPubMed
Israel, E., Banerjee, T. R., Fitzmaurice, G. M., et al.Effects of inhaled glucocorticoids on bone density in premenopausal women. N. Engl. J. Med. 1401; 345:941–7.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×